Open AccessDelayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor
Author(s) -
Mutasem Elfalah,
Saif Aldeen AlRyalat,
Mario Damiano Toro,
Robert Ręjdak,
Sandrine Zweifel,
Rashed Mustafa Nazzal,
Mohammed AbuAmeerh,
Osama H. Ababneh,
Almutez Gharaibeh,
Zuhair Sharif,
Jehad Meqbil,
Mo’ath AlShawabkeh,
Amal Alwreikat,
Muawyah Al Bdour,
Maysa AlHussaini,
Yacoub A. Yousef
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s289068
Subject(s) - medicine , macular edema , visual acuity , ophthalmology , macular degeneration , ranibizumab , retrospective cohort study , bevacizumab , surgery , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom